Skip to main content
Use this button to show the site search bar.
Antimicrobial Companion
Antimicrobial Companion
Menu
Toolkits
National Template
NHS Ayrshire & Arran
NHS Borders
NHS Dumfries & Galloway
NHS Fife
NHS Forth Valley
Golden Jubilee
NHS Grampian & Orkney
NHS Greater Glasgow & Clyde
NHS Highland & Western Isles
NHS Lanarkshire
NHS Lothian
NHS Shetland
NHS Tayside
About Us
Contact and Feedback
Support
Notifications
Home
Back
NHS Forth Valley
COVID-19 Guidance
COVID-19 Guidance
Version 3.0
General guidance
NHS Forth Valley Acute Care Bundle - Initial assessment and management of hospitalised patients with COVID-19
Corticosteroids in the treatment of suspected or confirmed COVID-19 infection
Treatment of patients hospitalised due to COVID-19 infection
Treatment of patients with symptomatic hospital-onset COVID-19
Paxlovid (nirmatrelvir/ritonavir) for patients with hospital-onset COVID-19
Remdesivir for patients in hospital with COVID-19 infection
Baricitinib for patients hospitalised due to COVID-19
IL-6 inhibitors in treatment of COVID-19
Non-severe (e.g. CURB-65 <3) Community acquired pneumonia complicating COVID-19
Severe (e.g. CURB65 ≥3) Community acquired pneumonia complicating COVID-19
Hospital acquired pneumonia complicating COVID-19
Alternative antibiotic regimes in COVID-19 patients
NHS Forth Valley
Vancomycin Dosage Calculator
Gentamicin Dosage Calculator
High Dose Antibiotic Therapy
Primary Care Guidance
Hospital Guidance
Paediatric Antibiotic Guidance - Hospital
Hospital at Home Guidance
Surgical Prophylaxis Guidance
COVID-19 Guidance
General guidance
NHS Forth Valley Acute Care Bundle - Initial assessment and management of hospitalised patients with COVID-19
Corticosteroids in the treatment of suspected or confirmed COVID-19 infection
Treatment of patients hospitalised due to COVID-19 infection
Treatment of patients with symptomatic hospital-onset COVID-19
Paxlovid (nirmatrelvir/ritonavir) for patients with hospital-onset COVID-19
Remdesivir for patients in hospital with COVID-19 infection
Baricitinib for patients hospitalised due to COVID-19
IL-6 inhibitors in treatment of COVID-19
Non-severe (e.g. CURB-65 <3) Community acquired pneumonia complicating COVID-19
Severe (e.g. CURB65 ≥3) Community acquired pneumonia complicating COVID-19
Hospital acquired pneumonia complicating COVID-19
Alternative antibiotic regimes in COVID-19 patients
UTI Decision Aid
Back to the top